Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

HRMYHRMY
10 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in HARMONY BIOSCIENCES HOLDINGS

Yes. Arrowstreet Capital holds 1,312,550 shares of HRMY (Harmony Biosciences Holdings), worth $47.8M, as of its Q2 2026 13F filing. It reduced the position by 69,563 shares (-5.0%) from Q1 2026. Arrowstreet Capital has held HRMY since Q3 2024, across 8 quarterly 13F filings.

Current Value

$47.8M

Current Shares

1.3M

Total Value Change

+$47.2M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.3M
-5.0%
$47.8M0.0%$36.41
0
2026-Q1
Decreased
1.4M
-7.3%
$38.7M0.0%$28.01
0
2025-Q4
Increased
1.5M
+15.2%
$55.8M0.0%$37.42
34
2025-Q3
Increased
1.3M
+42.8%
$35.7M0.0%$27.56
39
2025-Q2
Increased
906,909
+127.6%
$28.7M0.0%$31.60
46
2025-Q1
Increased
398,411
+34.3%
$13.2M0.0%$33.19
36
2024-Q4
Decreased
296,618
-6.6%
$10.2M0.0%$34.41
0
2024-Q3
New
317,566
-
$12.7M0.0%$40.00
39
2021-Q2
Exited
0
-100.0%
$00.0%$28.23
0
2021-Q1
New
17,134
-
$566,0000.0%$33.04
34

Other major holders of HRMY: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used